Ferromagnetic resonance for the quantification of superparamagnetic iron oxide nanoparticles in biological materials
Lionel F Gamarra1,2, Antonio J daCosta-Filho3, Javier B Mamani1, Rita de Cassia Ruiz4, Lorena F Pavon1, Tatiana T Sibov1, Ernanni D Vieira3, André C Silva1, Walter M Pontuschka5, Edson Amaro Jr1,2
1Instituto Israelita de Ensino e Pesquisa Albert Einstein, IIEPAE, São Paulo, Brazil; 2Instituto de Radiologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; 3Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, Brazil; 4Instituto Butantan, São Paulo, Brazil; 5Instituto de Física, Universidade de São Paulo, São Paulo, Brazil
Abstract: The aim of the present work is the presentation of a quantification methodology for the control of the amount of superparamagnetic iron oxide nanoparticles (SPIONs) administered in biological materials by means of the ferromagnetic resonance technique (FMR) applied to studies both in vivo and in vitro. The in vivo study consisted in the analysis of the elimination and biodistribution kinetics of SPIONs after intravenous administration in Wistar rats. The results were corroborated by X-ray fluorescence. For the in vitro study, a quantitative analysis of the concentration of SPIONs bound to the specific AC133 monoclonal antibodies was carried out in order to detect the expression of the antigenic epitopes (CD133) in stem cells from human umbilical cord blood. In both studies FMR has proven to be an efficient technique for the SPIONs quantification per volume unit (in vivo) or per labeled cell (in vitro).
Keywords: quantification, FMR, ferrofluid, biodistribution, nanoparticles
© 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.